CLEARSIGN TECHNOLOGIES CORP (CLIR) Announces Clinical Trial Update
CLEARSIGN TECHNOLOGIES CORP (CLIR) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: operations, operators
Diseases/Conditions: West Texas, continued growth across our product portfolio
📋 CLEARSIGN TECHNOLOGIES CORP (CLIR) - Clinical Trial Update
Filing Date: 2026-08-20
Accepted: 2026-08-20 16:15:27
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
No business developments data available.
Structured Data: